obsessive-compulsive%20disorder
OBSESSIVE-COMPULSIVE DISORDER
Obsessive-compulsive disorder is characterized by the presence of either obsessions or compulsions, but more commonly by both symptoms that can cause marked impairment or distress.
Obsession is a recurrent, persistent, intrusive, unwanted thought, image or urge that cause distressing emotions (eg anxiety and disgust).
Compulsion is a repetitive behavior or mental act that the person feels driven to perform, in order to lessen the distress caused by the obsession.
Anxiety is the central feature of obsessive-compulsive disorder.

Diagnosis

  • A clinical interview that elicits a history of intrusive thoughts or behavioral rituals is the primary method of establishing the diagnosis
  • Obsessive-compulsive disorder diagnostic criteria based on DSM-5 are the presence of symptoms of obsessions,compulsions or both.
    • Obsession symptoms include:
      • Intrusive unnecessary thoughts, urges or images that are recurrent & persistent causing significant anxiety or distress in an individual
      • The individual takes efforts of ignoring or suppressing such thoughts, urges or images or tries to neutralize them with some other thought or action (ie by performing compulsion)
    • Compulsion symptoms include:
      • The individual feels impelled to do repetitive behaviors (eg hand washing, ordering, checking) or mental acts (eg praying, counting, repeating words silently) as a response to an obsession or according to rules that must be strictly applied
      • The behaviors or mental acts are done to prevent/reduce anxiety or distress or to prevent some dreaded event or situation but these acts are not associated in a realistic way with what they are designed to neutralize or prevent or are clearly excessive
  • Based on DSM-5 criteria the above disturbances should be:
    • Time-consuming (>1 hour/day) or cause clinically serious distress or deterioration in social, occupational or other important areas of functioning
    • Not secondary to any medication, substance of abuse or another medical condition
    • Not associated with symptoms of other mental disorders (eg generalized anxiety disorder, body dysmorphic disorder, hoarding disorder, trichotillomania, excoriation disorder, stereotypic movement disorder, eating disorders, substance-related & addictive disorders, illness anxiety disorder, paraphilic disorders, disruptive impulse-control & conduct disorders, major depressive disorder, schizophrenia or autistic disorder)
  • According to DSM-5, specify obsessive-compulsive disorder if:
    • With good or fair insight when the patient knows that the disorder beliefs are definitely/probably not true or may or may not be true
    • With poor insight when the patient thinks that the disorder beliefs are probably true
    • With absent insight/delusional beliefs when the patient believes that the disorder beliefs are true
  •  The presence of a tic disorder prior to or during evaluation should be included when making the diagnosis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
19 Jun 2019
The choice between nonvitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) for stroke prevention appears to be complex and largely heterogenous across different, countries, a new study has found.
2 days ago
Monotherapy with tenofovir disoproxil fumarate increases virologic response for up to 240 weeks in pretreated patients with hepatitis B virus infection (HBV) who are resistant to entecavir and/or adefovir, a new study has found.
Elvira Manzano, 3 days ago
Long-term treatment with the interleukin-5 receptor alpha-directed cytolytic monoclonal antibody benralizumab led to long-term control of asthma, improvement in pulmonary function, and was safe in patients with severe eosinophilic asthma in the 2-year integrated analysis of the SIROCCO, CALIMA, and ZONDA pivotal studies plus the BORA extension study reported at ATS 2019.
Pearl Toh, 3 days ago
Emerging evidence is showing that the two major new classes of antidiabetic drugs — SGLT2* inhibitors and GLP-1** receptor agonists (RAs) — not only confer cardiovascular (CV) benefits to patients with type 2 diabetes (T2D), they also delay the loss of kidney function among these patients, potentially providing nephrologists with an additional tool in their armamentarium for managing patients with chronic kidney disease (CKD) in the future.